Search Results for "Warfarin In Vte"

02:51 EDT 2nd September 2014 | BioPortfolio

Original Source: Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes.

INTRODUCTION: Few studies have investigated current practices in the USA relating to warfarin use and monitoring, or the effects of warfarin discontinuation on risk of venous thromboembolism (VTE) and bleeding complications. This study investigated the effect of warfarin discontinuation on rates of VTE recurrence in a real-world setting. METHODS: Integrated Healthcare Information Services database records from January 2003 to September 2007 from patients aged at least 18 years, hospitalized for VTE, and wit...

Matching Channels

Vitamin K

Vitamin K is a group of 2-methilo-naphthoquinone derivatives. There are three notable forms of vitamin K; K1 which can be synthesized by plants, K2 which can be formed by natural bacteria in the int...

Matching News

Rethinking Warfarin for Atrial Fibrillation

Full-page newspaper advertisements and a series of television commercials have urged patients with atrial fibrillation to “rethink warfarin” in favor of Eliquis (apixaban – Bristol-Myers Squibb)...

Return to Warfarin Okay After TBI?

(MedPage Today) -- Restarting warfarin (Coumadin) after a traumatic brain injury (TBI) improved overall outcomes despite the bleeding risk, an observational Medicare study showed.

Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation

To the Editor Dr Carrero and colleagues evaluated the influence of chronic kidney disease (CKD) on the efficacy and safety of warfarin therapy in a population with atrial fibrillation and recent myoca...

Warfarin for Long-term Psychosis Remission?

Patients with schizophrenia treated with warfarin for deep venous thrombosis attained remission of psychotic symptoms and remained free of psychotropics for up to 11 years. Medscape Medical News

Stroke Rounds: APOE Tied to Warfarin Brain Bleeds (CME/CE)

(MedPage Today) -- Apolipoprotein E gene variants epsilon-2 and epsilon-4 were strong risk factors for warfarin-induced intracerebral hemorrhage independent of the drug's anticoagulant effect.

Stroke Rounds: Warfarin No Help for Dialysis Patients

(MedPage Today) -- The risk-benefit balance did not appear to be favorable for warfarin in patients with atrial fibrillation who were undergoing dialysis, a retrospective study showed.

Stroke Rounds: No Help From Genotype-Guided Warfarin Dosing

(MedPage Today) -- Using a patient?s genotype to guide the initial dosing of warfarin or its analogues does not appear to be better than dosing based on clinical characteristics, a meta-analysis showe...

Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients With Atrial Fibrillation

Clinical QuestionIs treatment with factor Xa inhibitors associated with better efficacy and safety compared with the vitamin K antagonist warfarin for preventing strokes or other systemic embolic even...

Matching PubMed Articles

Antithrombin Levels Are Unaffected by Warfarin Use.

Context.-The results of studies among patients with antithrombin deficiency have suggested that the use of warfarin will increase the level of antithrombin. Objective.-To reevaluate the effect of warf...

The effects of fasting in muslim patients taking warfarin.

Anticoagulation with warfarin is influenced by dietary changes but the effect of fasting on warfarin therapy is unknown.

Acute warfarin toxicity: An unanticipated consequence of amoxicillin/clavulanate administration.

Patient: Male, 53 Final Diagnosis: Acute Warfarin toxicity Symptoms: - Medication: Warfarin Clinical Procedure: - Specialty: Hematology.

VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.

Warfarin is the most commonly prescribed anticoagulant drug; however, a narrow therapeutic range and a high risk of bleeding or stroke complicate its clinical use. Warfarin resistance was defined as p...

Warfarin dose requirements in a patient with the CYP2C9*14 allele.

We describe a 64-year-old male of Indian descent with a history of atrial fibrillation who was started on warfarin after hospital admission for acute stroke. He received genotype-guided warfarin dosin...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement